Currently, Trinity Pharma is exporting pharmaceuticals to Lesotho, Botswana, Zambia, Malawi and Swaziland. Opportunities are being explored to extend their footprint in other African markets.

Products are supplied on a tender and buy-out basis. With the regulatory requirements being different to South Africa, Trinity Pharma offers a substantially wider range of products in these territories.

Supplying products on a buy-out basis means that Trinity Pharma needs to source quality products at affordable prices and with minimal lead times. Due to a wide network of international manufacturers, the company is able to supply products across all therapeutic classes.

Products are supplied directly from manufacturer to the customer which secures the best possible prices.

Quality is essential and Trinity Pharma only sources products from reputable manufacturers that meet the customers' regulatory requirements. Post-importation testing and facility inspection is done by Trinity Pharma if requested to ensure adherence to their high quality standards.